Center for Applied Genomics

Today's Research Becomes Tomorrows Cure

Home
Home
About Us
About Us
- Our Team
  Our Team
- Our Mission
  Our Mission
- Publications
  Publications
- Search
  Search
CAG Services
CAG Services
- For Researchers
  For Researchers
- Pricing and Services
  Pricing and Services
- Our Technology
  Our Technology
- Downloads (CAG Forms and Software)
  Downloads (CAG Forms and Software)
CAG Studies
CAG Studies
- Disease Studies
  Disease Studies
- ADHD
  ADHD
- Asthma and Autoimmune Diseases
  Asthma and Autoimmune Diseases
- Autism
  Autism
- Cancers and Tumors
  Cancers and Tumors
- IBD - Crohn's Disease and Ulcerative Colitis
  IBD - Crohn's Disease and Ulcerative Colitis
- Rare Diseases
  Rare Diseases
For Participants
For Participants
- For Participants
  For Participants
- What's involved?
  What's involved?
- FAQs
  FAQs
- Resources and Genetics Info
  Resources and Genetics Info
Media
Media
- Media
  Media
- CAG in the Press
  CAG in the Press
- Privacy Policies
  Privacy Policies
Support CAG
Support CAG
- Pediatric Cancer
  Pediatric Cancer
- Psychiatric Disorders
  Psychiatric Disorders
- Rare Disease Program
  Rare Disease Program

Homepage Slider

We Provide 10x Genomics Sequencing with Long Read Solutions for ...

- Access to High/Low Complexity Regions
- Access to Repetitive Regions
- Structural Variants and Complex Rearrangements
- Copy Number Determination
- Single cell sequencing

Global Screening Array for under $50! Offers predictive risk screening and large-scale GWAS featuring ...

- Highly predictive hand-curated content
- 660,000 high-value markers
- Up to 50,000 custom markers
- Imputation to match any genotyping platform

Contact Us to learn more or receive a free consultation.

CAG wins $3.6 million NIH grant for study on patient care decisions.

Researchers will analyze DNA sequencing in common pediatric conditions and evaluate how sharing this information with patients impacts treatment decisions.

Read more at PhillyVoice.

CAG and Medgenics Announce Rare & Orphan Disease Collaboration.

Partnership will bring together the premier pediatric genomics research organization and ex vivo gene therapy innovator.

Read more, including interviews with CHOP, CAG and Medgenics leaders at GlobeNewswire.

CAG Researchers Discover Three Possible Autism Treatment Targets

DNA analysis from thousands of patients uncovers gene networks that offer attractive targets for developing new treatments.

Read more at Drug Discovery & Development.

Review the research paper from Nature Communications.

Recent News

Illumina to Acquire Pacific Biosciences

Air Pollution The ‘New Tobacco’, Warns WHO

Genetic Migraine Risk in African-American Kids

Prenatal CRISPR Treatment Shows Promise

About Us
Our aim is to discover the genetic causes of prevalent childhood diseases and translate findings into medical innovations.

For Participants

The Center is engaged in a number of major research projects, and we aim to collect and analyze data from more than 100,000 children.

CAG Service

We collaborate with researchers in the academic, public, and private sectors. The Center has the capacity to genotype thousands of samples per week.

CAG Studies

We currently have more than 50 active disease projects - internally and in collaboration with research teams in North America, Europe, and Asia.

CAG Media

CAG regularly features in national and international media. Watch videos and read reviews of our most prominent research.

Support CAG

CAG is discovering new and better ways to diagnose and treat childhood disorders. Your support can help launch innovative research projects.